Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 16781–16800 of 17,529 recalls

March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: HCG 1000 units/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Cyclosporine 1% ophthalmic drops

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Cyclosporine 2% ophthalmic

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test cyp 75 mg-estradiol cyp 5 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Laser ophthalmic drops

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Phenylephrine-cyclopentolate

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Acetylcysteine 10 % Solution

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Vancomycin 50 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Methylcobalamin 12.5 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Sodium Chloride (23.4%)

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Mitomycin (modified) 0.02% solution

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Mitomycin 0.04% solution

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Diazepam 5 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Medroxyprogesterone 50 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Estradiol Valerate 20 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 19, 2013· Teva Pharmaceuticals USA, Inc.

Recalled Item: Disulfiram Tablets USP 250 mg

The Issue: CGMP Deviation; cotton coil is missing in some

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 19, 2013· Dr. Reddy'S Laboratories

Recalled Item: Tizanidine Tablets USP

The Issue: Labeling Illegible: There is a possibility that the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 18, 2013· West-ward Pharmaceutical Corp.

Recalled Item: Ethambutol Hydrochloride Tablets

The Issue: Subpotent Drug: Out Of Specification results for assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 18, 2013· Apotex Corp.

Recalled Item: Piperacillin and Tazobactam for Injection

The Issue: Crystallization: Potential to exhibit precipitation/crystallization in IV bag

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 18, 2013· Boehringer Ingelheim Roxane Inc

Recalled Item: Oxcarbazepine Tablets

The Issue: SubPotent Drug: The firm discovered out of specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund